Key benchmark indices extended early gains and hit the day's high in morning trade. Value buying emerged after a heavy selling in the previous trading session. The Nifty marched towards the 14,800 mark. All the sectoral indices on the NSE traded in the green.
At 10:25 IST, the barometer index, the S&P BSE Sensex, was up 834 points or 1.7% at 49,934.67. The Nifty 50 index was up 244.55 points or 1.68% at 14,773.30.
In broader market, the S&P BSE Mid-Cap index was up 1.15% while the S&P BSE Small-Cap index was up 1.43%.
The market breadth, indicating the overall health of the market, was strong. On the BSE, 1889 shares rose and 687 shares fell.
A total of 159 shares were unchanged.
Economy:
The seasonally adjusted IHS Markit India Manufacturing Purchasing Managers' Index (PMI) stood at 57.5 in February 2021, highlighting a strong improvement in operating conditions that was broadly similar to that recorded in January (57.7). The headline figure remained above its long-run average of 53.6.
India's economy returned to growth in its fiscal third quarter after a recession earlier in 2020. Gross domestic product grew 0.4% in October-December compared with the same period a year earlier, data released by the National Statistics Office on Friday showed. That compared with revised contractions of 7.3% in July-September and 24.4% in April-June.
The output of eight core infrastructure sectors grew marginally by 0.1% in January, mainly due to growth in the production of fertiliser, steel and electricity. The core sectors had expanded by 2.2% in January 2020, according to the provisional data released by the Commerce and Industry Ministry on Friday.
COVID-19 Update:
Total COVID-19 confirmed cases worldwide stood at 114,051,765 with 25,30,563 deaths. India reported 168,627 active cases of COVID-19 infection and 157,157 deaths while 107,86,457 patients have been discharged, according to the data from the Ministry of Health and Family Welfare, Government of India.
Buzzing Index:
The Nifty IT index surged 1.66% to 24,704.30 on bargain hunting after tumbling 2.3% in previous trading session.
Tech Mahindra (up 3.2%), HCL Tech (up 2.19%), TCS (up 2.06%), Infosys (up 1.65%), Wipro (up 1.27%), Info Edge (up 0.95%) and Coforge (up 0.43%) were top gainers in IT segment.
Stocks in Spotlight:
KEC International advanced 2.92% after the EPC company bagged new orders of Rs 1,140 crore across its various businesses.
Biocon gained 0.63%. Biocon Biologics, a subsidiary of Biocon, announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the marketing authorization of their biosimilar Bevacizumab, co-developed with Viatris, to be marketed as Abevmy (injection bevacizumab 100 mg and 400 mg).
Abevmy is a biosimilar to Roche's Avastin, prescribed for all indications including metastatic colorectal carcinoma, metastatic breast cancer, non-small-cell lung carcinoma, glioblastoma, ovarian, cervical and renal cancer as part of a specific regimen.
Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)
Dear Reader,
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.
Digital Editor
RECOMMENDED FOR YOU